{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:34:47Z","timestamp":1793230487533,"version":"4.5.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/2229-5178.131079","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T04:34:28Z","timestamp":1398054868000},"page":"128","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of terbinafine hydrochloride 1% cream vs eberconazole nitrate 1% cream in localised tinea corporis and tinea cruris"],"prefix":"10.4103","volume":"5","author":[{"given":"SanjivV","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru","family":"Aghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Bisati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.131079-1","first-page":"217","volume-title":"Eberconazole-pharmacological and clinical review","author":"Moodahadu-Bangera","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.131079-2","first-page":"16","volume-title":"Profile of a new topical antimycotic, eberconazole","author":"Font","year":"1995","journal-title":"Rev Iberoam Micol"},{"key":"key-10.4103\/2229-5178.131079-3","first-page":"2","volume-title":"Terbinafine: Mode of action and properties of the squalene epoxidase inhibition","author":"Ryder","year":"1992","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.131079-4","first-page":"14","volume-title":"Tinea corporis\/cruris: new treatment options","author":"Van","year":"1997","journal-title":"Dermatology"},{"key":"key-10.4103\/2229-5178.131079-5","first-page":"300","volume-title":"Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris.A placebo-controlled study","author":"Budimulja","year":"2001","journal-title":"Mycoses"},{"key":"key-10.4103\/2229-5178.131079-6","first-page":"317","volume-title":"Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream 1% and 2%: A phase II dose-finding pilot study","author":"del","year":"1995","journal-title":"Mycoses"},{"key":"key-10.4103\/2229-5178.131079-7","first-page":"600","volume-title":"Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: Multicenter, randomized, double-blind, comparative trial with miconazole 2% cream","author":"Repiso","year":"2006","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2229-5178.131079-8","first-page":"173","volume-title":"A double blind randomized comparative trial: eberconazole 1% cream versus clotriamzole 1% cream twice daily in candida and dermatophyte skin infections","author":"Del","year":"2001","journal-title":"Mycosis"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:23:24Z","timestamp":1786649004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2229-5178.131079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"alternative-id":["131079"],"URL":"https:\/\/doi.org\/10.4103\/2229-5178.131079","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}